Quality of Life and Psychological Distress in Patients with Acute Myeloid Leukemia (AML)

Conclusion: Older patients with AML receiving intensive and non-intensive chemotherapy experience similar QOL impairments and high rates of psychological distress. These findings underscore the need to develop supportive care interventions for older patients with AML, regardless of their initial treatment strategy.DisclosuresBrunner: Takeda: Research Funding; Novartis: Research Funding; Celgene: Consultancy, Research Funding. Fathi: Celgene: Consultancy, Honoraria, Research Funding; Jazz: Honoraria; Boston Biomedical: Consultancy, Honoraria; Astellas: Honoraria; Agios: Honoraria, Research Funding; Seattle Genetics: Consultancy, Honoraria; Takeda: Consultancy, Honoraria. DeAngelo: ARIAD: Consultancy, Research Funding; Takeda: Honoraria; Amgen: Consultancy; Shire: Honoraria; Blueprint Medicines: Honoraria, Research Funding; Pfizer Inc: Consultancy, Honoraria; Novartis Pharmaceuticals Corporation: Consultancy, Honoraria; BMS: Consultancy; Glycomimetics: Research Funding; Incyte: Consultancy, Honoraria. Amrein: Takeda: Research Funding.

Source: Blood - November 21, 2018 Category: Hematology Authors: El-Jawahri, A., Waldman, L., Greer, J., Abel, G. A., Steensma, D. P., Brunner, A. M., Fathi, A. T., DeAngelo, D. J., Wadleigh, M., Hobbs, G. S., Amrein, P. C., Stone, R. M., Temel, J. S. Tags: 904. Outcomes Research-Malignant Conditions: Poster I Source Type: research